The story of Viagra presents a intricate picture for shareholders. While the initial launch generated massive gains, the end of its exclusive rights opened the floodgates to cheaper competitors, dramatically https://bookmarkblast.com/story21731794/viagra-and-big-pharma-a-risky-opportunity